Coeli Lopes
Concepts (208)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Ion Channel Gating | 7 | 2000 | 42 |
Why?
| Phosphatidylinositol 4,5-Diphosphate | 10 | 2002 | 15 |
Why?
| Potassium Channels | 9 | 2000 | 33 |
Why?
| KCNQ1 Potassium Channel | 4 | 2009 | 13 |
Why?
| Long QT Syndrome | 5 | 2010 | 35 |
Why?
| Protein Kinase C | 2 | 2009 | 93 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 2 | 2007 | 62 |
Why?
| Death, Sudden, Cardiac | 4 | 2010 | 31 |
Why?
| Mutation | 8 | 2002 | 340 |
Why?
| Romano-Ward Syndrome | 2 | 2009 | 7 |
Why?
| GTP-Binding Protein alpha Subunits, Gq-G11 | 2 | 2009 | 9 |
Why?
| Genetic Predisposition to Disease | 3 | 2010 | 131 |
Why?
| Receptors, G-Protein-Coupled | 2 | 2009 | 41 |
Why?
| Adrenergic Antagonists | 1 | 2010 | 2 |
Why?
| Oocytes | 8 | 2001 | 45 |
Why?
| Receptors, Adrenergic, alpha-1 | 1 | 2010 | 9 |
Why?
| Plant Transpiration | 1 | 2010 | 2 |
Why?
| Vitis | 1 | 2010 | 5 |
Why?
| Channelopathies | 1 | 2010 | 11 |
Why?
| Ventricular Remodeling | 1 | 2010 | 21 |
Why?
| Receptors, Adrenergic, beta | 1 | 2010 | 35 |
Why?
| Water | 1 | 2010 | 85 |
Why?
| Xenopus | 7 | 2002 | 37 |
Why?
| Adaptation, Physiological | 1 | 2010 | 74 |
Why?
| Arrhythmias, Cardiac | 1 | 2010 | 65 |
Why?
| Potassium Channels, Inwardly Rectifying | 4 | 2002 | 7 |
Why?
| Potassium | 3 | 2000 | 98 |
Why?
| Genotype | 5 | 2010 | 175 |
Why?
| Hypertension | 1 | 2010 | 161 |
Why?
| Xenopus laevis | 8 | 2000 | 49 |
Why?
| Conserved Sequence | 2 | 2002 | 73 |
Why?
| Type C Phospholipases | 1 | 2007 | 34 |
Why?
| Potassium Channels, Voltage-Gated | 2 | 2003 | 17 |
Why?
| Animals | 18 | 2000 | 1031 |
Why?
| Protons | 2 | 2000 | 30 |
Why?
| Hydrolysis | 4 | 2003 | 57 |
Why?
| Phenotype | 3 | 2010 | 303 |
Why?
| G Protein-Coupled Inwardly-Rectifying Potassium Channels | 4 | 2002 | 2 |
Why?
| Membrane Potentials | 4 | 2000 | 99 |
Why?
| Electrophysiology | 2 | 2007 | 101 |
Why?
| Humans | 15 | 2003 | 1856 |
Why?
| Acetylcholine | 2 | 2007 | 49 |
Why?
| Risk Factors | 5 | 2009 | 555 |
Why?
| Enzyme Activation | 2 | 2009 | 177 |
Why?
| Protein Structure, Tertiary | 3 | 2005 | 163 |
Why?
| Electrocardiography | 2 | 2010 | 132 |
Why?
| Kinetics | 4 | 2000 | 349 |
Why?
| Child | 4 | 2009 | 749 |
Why?
| Molecular Sequence Data | 5 | 2000 | 404 |
Why?
| Models, Biological | 2 | 2009 | 410 |
Why?
| Female | 10 | 2001 | 1643 |
Why?
| Patch-Clamp Techniques | 4 | 2002 | 47 |
Why?
| Heart Arrest | 2 | 2010 | 37 |
Why?
| Proportional Hazards Models | 2 | 2010 | 123 |
Why?
| Rats | 4 | 2003 | 530 |
Why?
| Young Adult | 3 | 2009 | 380 |
Why?
| Amino Acid Sequence | 4 | 2000 | 319 |
Why?
| Calcium | 3 | 2003 | 208 |
Why?
| Kv1.1 Potassium Channel | 1 | 2010 | 6 |
Why?
| Bisoprolol | 1 | 2010 | 1 |
Why?
| Propanolamines | 1 | 2010 | 12 |
Why?
| Hearing Loss, Sensorineural | 1 | 2010 | 18 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2011 | 39 |
Why?
| Carbazoles | 1 | 2010 | 21 |
Why?
| Rats, Inbred SHR | 1 | 2010 | 24 |
Why?
| Propranolol | 1 | 2010 | 34 |
Why?
| Kaplan-Meier Estimate | 1 | 2011 | 89 |
Why?
| Abscisic Acid | 1 | 2010 | 2 |
Why?
| Thallium | 1 | 2010 | 6 |
Why?
| Registries | 1 | 2011 | 83 |
Why?
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2010 | 19 |
Why?
| GTP-Binding Protein beta Subunits | 1 | 2010 | 10 |
Why?
| Biological Assay | 1 | 2010 | 58 |
Why?
| GTP-Binding Protein gamma Subunits | 1 | 2010 | 10 |
Why?
| Spectrometry, Fluorescence | 1 | 2010 | 59 |
Why?
| Seizures | 1 | 2010 | 79 |
Why?
| Intracellular Space | 1 | 2009 | 14 |
Why?
| Computer Simulation | 1 | 2011 | 134 |
Why?
| Mitochondria, Heart | 1 | 2010 | 20 |
Why?
| Ion Channels | 2 | 2005 | 61 |
Why?
| Microscopy, Confocal | 2 | 2003 | 105 |
Why?
| Mutation, Missense | 1 | 2009 | 59 |
Why?
| Transfection | 3 | 2003 | 237 |
Why?
| Polylysine | 2 | 2002 | 11 |
Why?
| Infant | 2 | 2009 | 464 |
Why?
| Male | 6 | 2009 | 1553 |
Why?
| Androstadienes | 2 | 2003 | 25 |
Why?
| Fluorescence Resonance Energy Transfer | 1 | 2007 | 18 |
Why?
| Child, Preschool | 2 | 2009 | 554 |
Why?
| Adolescent | 3 | 2009 | 891 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 2007 | 83 |
Why?
| Heart Failure | 1 | 2010 | 106 |
Why?
| Disease Models, Animal | 1 | 2010 | 349 |
Why?
| DNA, Complementary | 3 | 2000 | 139 |
Why?
| Phosphorylation | 1 | 2009 | 224 |
Why?
| Thermosensing | 1 | 2005 | 2 |
Why?
| Mice | 4 | 2000 | 623 |
Why?
| Cold Temperature | 1 | 2005 | 59 |
Why?
| Sensory Receptor Cells | 1 | 2005 | 20 |
Why?
| Dose-Response Relationship, Drug | 1 | 2007 | 431 |
Why?
| Receptor, Epidermal Growth Factor | 1 | 2004 | 54 |
Why?
| Kidney | 1 | 2007 | 223 |
Why?
| Receptors, Muscarinic | 1 | 2003 | 16 |
Why?
| Phosphatidylinositols | 1 | 2003 | 17 |
Why?
| Myocardial Contraction | 1 | 2003 | 52 |
Why?
| Signal Transduction | 2 | 2003 | 313 |
Why?
| Calcium-Binding Proteins | 1 | 2003 | 49 |
Why?
| Glycogen Storage Disease Type IV | 1 | 2002 | 1 |
Why?
| Bartter Syndrome | 1 | 2002 | 2 |
Why?
| Neoplasm Proteins | 1 | 2005 | 110 |
Why?
| Time Factors | 1 | 2010 | 896 |
Why?
| Cell Line | 1 | 2007 | 375 |
Why?
| Adult | 3 | 2009 | 1317 |
Why?
| Barium | 1 | 2001 | 16 |
Why?
| Tandem Repeat Sequences | 1 | 2001 | 8 |
Why?
| Electric Stimulation | 1 | 2001 | 101 |
Why?
| Potassium Channels, Tandem Pore Domain | 1 | 2000 | 1 |
Why?
| Dimerization | 1 | 2001 | 92 |
Why?
| Point Mutation | 1 | 2001 | 122 |
Why?
| Protein Conformation | 1 | 2001 | 123 |
Why?
| Cloning, Molecular | 1 | 2001 | 183 |
Why?
| Hydrogen-Ion Concentration | 1 | 2001 | 176 |
Why?
| Nerve Tissue Proteins | 1 | 2000 | 128 |
Why?
| Base Sequence | 1 | 2000 | 371 |
Why?
| Neurons | 1 | 2003 | 195 |
Why?
| Mice, Transgenic | 2 | 2003 | 209 |
Why?
| Rats, Sprague-Dawley | 2 | 2003 | 257 |
Why?
| COS Cells | 2 | 2002 | 73 |
Why?
| Mice, Inbred C57BL | 2 | 2003 | 318 |
Why?
| HEK293 Cells | 1 | 2010 | 16 |
Why?
| Hypokalemia | 1 | 2010 | 14 |
Why?
| Ataxia | 1 | 2010 | 17 |
Why?
| Alkalosis | 1 | 2010 | 12 |
Why?
| Molecular Biology | 1 | 2010 | 38 |
Why?
| Xanthenes | 1 | 2010 | 8 |
Why?
| World Health | 1 | 2011 | 41 |
Why?
| Arousal | 1 | 2010 | 37 |
Why?
| HL-60 Cells | 1 | 2010 | 28 |
Why?
| Uridine Diphosphate | 1 | 2010 | 4 |
Why?
| Fluoxetine | 1 | 2010 | 8 |
Why?
| Mitochondrial Swelling | 1 | 2010 | 8 |
Why?
| Osmosis | 1 | 2010 | 14 |
Why?
| Coumarins | 1 | 2010 | 8 |
Why?
| Ether-A-Go-Go Potassium Channels | 1 | 2010 | 9 |
Why?
| Cyclohexanes | 1 | 2010 | 15 |
Why?
| Syndrome | 1 | 2010 | 142 |
Why?
| Syncope | 1 | 2010 | 24 |
Why?
| Antidepressive Agents, Second-Generation | 1 | 2010 | 13 |
Why?
| Intellectual Disability | 1 | 2010 | 51 |
Why?
| Fluorescent Antibody Technique | 1 | 2010 | 164 |
Why?
| Glycine | 1 | 2010 | 40 |
Why?
| Models, Animal | 1 | 2010 | 85 |
Why?
| Immunoblotting | 1 | 2010 | 119 |
Why?
| Benzothiazoles | 1 | 2010 | 22 |
Why?
| Ischemic Preconditioning, Myocardial | 1 | 2010 | 9 |
Why?
| Perfusion | 1 | 2010 | 73 |
Why?
| Adrenergic beta-Antagonists | 1 | 2010 | 47 |
Why?
| Recombinant Proteins | 2 | 2002 | 290 |
Why?
| Myocytes, Cardiac | 1 | 2010 | 40 |
Why?
| Exercise | 1 | 2010 | 82 |
Why?
| Myocardial Reperfusion Injury | 1 | 2010 | 29 |
Why?
| Fluorescent Dyes | 1 | 2010 | 115 |
Why?
| Gene Expression | 2 | 2002 | 291 |
Why?
| Survival Rate | 1 | 2011 | 250 |
Why?
| Sex Factors | 1 | 2010 | 284 |
Why?
| Computational Biology | 1 | 2009 | 39 |
Why?
| Analysis of Variance | 1 | 2010 | 339 |
Why?
| Disease Progression | 1 | 2010 | 244 |
Why?
| Adenosine Triphosphate | 1 | 2010 | 121 |
Why?
| Prognosis | 1 | 2011 | 388 |
Why?
| Reproducibility of Results | 1 | 2010 | 391 |
Why?
| Risk Assessment | 1 | 2010 | 324 |
Why?
| TRPV Cation Channels | 1 | 2005 | 4 |
Why?
| Menthol | 1 | 2005 | 5 |
Why?
| Cardiovascular Diseases | 1 | 2009 | 127 |
Why?
| Neural Inhibition | 1 | 2005 | 30 |
Why?
| Cercopithecus aethiops | 1 | 2005 | 67 |
Why?
| Infant, Newborn | 1 | 2009 | 389 |
Why?
| KCNQ2 Potassium Channel | 1 | 2003 | 1 |
Why?
| KCNQ3 Potassium Channel | 1 | 2003 | 1 |
Why?
| Follow-Up Studies | 1 | 2009 | 553 |
Why?
| Receptor, Muscarinic M1 | 1 | 2003 | 4 |
Why?
| Bradykinin | 1 | 2003 | 12 |
Why?
| Calcium Channels | 1 | 2005 | 52 |
Why?
| Tetraethylammonium | 1 | 2003 | 9 |
Why?
| Acyl Coenzyme A | 1 | 2003 | 5 |
Why?
| Superior Cervical Ganglion | 1 | 2003 | 5 |
Why?
| Second Messenger Systems | 1 | 2003 | 19 |
Why?
| Electric Conductivity | 1 | 2003 | 42 |
Why?
| Cardiomyopathies | 1 | 2003 | 43 |
Why?
| Calcium Channels, L-Type | 1 | 2003 | 15 |
Why?
| Mutagenesis, Site-Directed | 1 | 2004 | 126 |
Why?
| Mice, Inbred C3H | 1 | 2003 | 86 |
Why?
| Calcium Signaling | 1 | 2005 | 52 |
Why?
| CHO Cells | 1 | 2003 | 65 |
Why?
| Ryanodine Receptor Calcium Release Channel | 1 | 2003 | 21 |
Why?
| Potassium Channel Blockers | 1 | 2002 | 12 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2003 | 67 |
Why?
| Cricetinae | 1 | 2003 | 130 |
Why?
| Amino Acid Substitution | 1 | 2002 | 68 |
Why?
| Cysteine | 1 | 2002 | 52 |
Why?
| Myocardium | 1 | 2003 | 119 |
Why?
| Membrane Proteins | 1 | 2005 | 233 |
Why?
| Enzyme Inhibitors | 1 | 2003 | 216 |
Why?
| Immunohistochemistry | 1 | 2003 | 355 |
Why?
| Aged | 1 | 2011 | 988 |
Why?
| Middle Aged | 1 | 2011 | 1161 |
Why?
| Cells, Cultured | 1 | 2003 | 447 |
Why?
|
|
Lopes's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
